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Long-range intramolecular interactionsts that the ﬁbrillation of α-synuclein is a critical step in the development of
Parkinson's disease. In vitro, α-synuclein forms ﬁbrils with morphologies and a staining characteristic similar
to those extracted from disease-affected brain. Monomeric α-synuclein is an intrinsically disordered protein,
with three Tyr residues in the C-terminal region, one in the N-terminus, and lacking Trp. It is thought that
interactions between the C-terminus and the central portion of the molecule may prevent or minimize
aggregation/ﬁbrillation. To test this hypothesis we examined the importance of the Tyr residues on the
propensity for α-synuclein to ﬁbrillate in vitro. Fibril formation of α-synuclein was completely inhibited, in
the timescale over which measurements were made, by replacing the three C-terminal Tyr residues with Ala.
In addition, substitution of Tyr133 by Ala also resulted in the absence of ﬁbrillation, whereas the individual
Y125A and Y136A mutants showed limited inhibition. Replacement of Tyr39 by Ala also resulted in
substantial inhibition of ﬁbrillation. Structural analysis showed that the Y133A mutant had a substantially
different conformation, rich in α-helical secondary structure, as compared with the wild-type and other
mutants, although the formation of any tertiary structure has not been observed as can be judged from near-
UV-CD spectra. These observations suggest that the long-range intramolecular interactions between the N-
and C-termini of α-synuclein are likely to be crucial to the ﬁbrillation process.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionParkinson's disease (PD) is the second most common neurode-
generative disease, affecting 1–2% of the population over the age of 65.
It involves the loss of dopaminergic neurons in the substantia nigra; a
process that leads to decreased dopamine levels in the striatum
causing symptoms such as tremors, rigidity of the muscles, and
bradykinesia. While the exact mechanism of PD pathogenesis is not
known, aggregation of the presynaptic proteinα-synuclein is believed
to play a critical role in the etiology of the disease [1–3]. The function
of α-synuclein still remains unknown. However, a signiﬁcant fraction
of α-synuclein is localized within membrane fractions, especially
synaptic vesicles associated with the vesicular transport processes.
These observations suggest that α-synuclein plays a role in vesicular
trafﬁcking [4–8].
Wild-type α-synuclein is a 140 amino acid protein and is
intrinsically disordered under physiological conditions in vitro. The
overall structure ofα-synuclein includes a highly conservedN-terminalvin T; CD, circular dichroism;
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l rights reserved.domain (residues 1–95) containing seven 11-amino acid imperfect
repeats with a consensus sequence of KTKEGV, a lipid binding motif.
The highly acidic C-terminal domain contains three of the four tyrosine
residues at positions 125,133 and 136. The fourth Tyr residue is located
at position 39. There are no Trp residues inα-synuclein. Recent studies
have shown thatmonomericα-synuclein has amore compact structure
than expected for a completely unfolded polypeptide and this
compactness has been linked to inhibition of ﬁbrillation due to burial
of the hydrophobic NAC domain [9–13]. Small angle X-ray scattering
analysis showed that the radius of gyration, Rg, which is used to
describe the dimensions of polypeptide chain, is ∼40 Å of native α-
synuclein, which is much larger than that predicted for a folded
globular protein of 140 residues (15 Å), but signiﬁcantly smaller than
that for a fully unfolded random coil (52 Å) [14]. Recently, NMR studies
have shown that α-synuclein adopts an ensemble of conformations
that are stabilized by long-range interactions [9]. In particular, a long-
range intramolecular interaction between the C-terminal region
(residues 120–140) and the central part of α-synuclein (residues 30–
100) was noted [9]. This interactionwas proposed to inhibit ﬁbrillation,
and could arise from electrostatic or hydrophobic or both types of
interactions. If hydrophobic interactions are important, then the cluster
of three Tyr residues in the C-terminus is likely to play an important
role in aggregation and ﬁbrillation. To delve into the detailed
mechanism the tyrosine residues play in the aggregation process, we
created Tyr to Ala mutants of α-synuclein and assessed the impact of
the mutations on the conformation and propensity to form ﬁbrils.
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2.1. Expression of wild-type and Tyr→ Ala mutant recombinant human
α-synuclein
Human wild-type α-synuclein cDNA was cloned into the bacterial
expression vector pRK172. The resultant construct was then used as a
template for PCR based mutagenesis. Tyr to Ala translations were
accomplished by mutating insert codons, TAT to GCT, at selected
locations.Mutagenesis and full vector PCRampliﬁcationwere performed
using the QuickChange mutagenesis kit (Stratagene, LaJolla, CA). Primer
selection and thermocycling conditions were determined using the
QuickChange primer design program. Primer synthesis was performed
under standard conditions (Integrated DNA Technologies, Coralville, IA)
and primers were used at a ﬁnal concentration of 100 ng/μl. Transfor-
mations and selection were performed using E. coli BL-21(DE3) com-
petent cells (Stratagene) and carbenicillin (75 μg/mL) LB media. Insert
sequences were conﬁrmed with forward and reverse sequencing using
pRK172ﬂankingprimers (UCBerkeleyDNA sequencing facility) andpair-
wise aligned with the starting sequence. ESI-MS was performed on the
protein products to conﬁrm themass changeswith the associatedmuta-
tion. Single mutant α-synuclein constructs (Y39A, Y125A, Y133A and
Y136A) and triple mutant α-synuclein Y(125,133,136)A were generated.
2.2. Expression and puriﬁcation of wild-type and Tyr → Ala mutant
recombinant human α-synuclein
Induction of both wild-type and mutant synuclein was controlled
under both the lac operon and T7 promoter in pRK172 transformed BL-
21(DE3) cells. Induced cellswere harvested bycentrifugation and lysed
using 0.1% Triton-X100 and sonication. Lysate was then clariﬁed in a
two-step ammonium sulfate precipitation of 30 and 50% saturation in
the presence of 1 mM EDTA and 200 μM PMSF. Precipitate was
removed by centrifugation at 4 °C and 13,000 rpm in a JA-20 rotor.
Precipitate from the 50% saturation of ammoniumsulfatewas collected
and dissolved in 20 mM Tris/50 mM NaCl pH 7.5 by overnight dialysis
and this was α-synuclein-containing fraction used for the experi-
ments. Sampleswere puriﬁed usingHiPrep 16/10 DEAE FastFlowanion
exchange chromatography (GE Healthcare Biosciences) at 4 °C.
Samples were eluted in 0.02% sodium azide/20 mM Tris pH 7.5 using
a linear gradient of NaCl from 50 mM to 250 mM in an elution volume
of 200 mL at 2 mL/min. The eluate was collected in 4 mL fractions and
the synuclein-containing fractions were located using the UV
absorbance and SDS-PAGE. Final conﬁrmation of the mutagenesis as
well as homogeneity of the samples was conﬁrmed with ESI-MS and
SDS-PAGE. Synuclein-containing fractions were pooled, dialyzed
overnight against MilliQ ultrapure water (Millipore), and lyophilized.
2.3. Protein preparation
Protein stock solutions were prepared by gravimetrically weigh-
ing an approximate weight of lyophilized protein and dissolving it in
MilliQ water at basic pH. Once dissolved, samples were adjusted to
100 mM NaCl/100 mM NaXHXPO4 pH 7.4, ultra-centrifuged to
remove particulates, and the concentrations were quantitated at
25 °C using an extinction coefﬁcient of ɛ275 nm=0.404 cm−1mg−1mL
for the wild-type; ɛ275 nm=0.303 cm−1mg−1mL for single mutants
and ɛ275 nm=0.101 cm−1mg−1mL for triple mutant. A Bio-Rad Protein
Assay (Bio-Rad, USA) was used to validate the values of extinction
coefﬁcients for the various mutants.
2.4. Materials
Thioﬂavin T (ThT) was obtained from Sigma (St. Louis, MO). All
buffers and solutions were prepared with nanopure water. Isopropyl-
β-D-1-thiogalactopyranoside (IPTG) was obtained from Sigma.2.5. Mass spectrometry
The molecular weight of the α-synuclein mutants and their
purity was conﬁrmed by ESI-MS analysis. The proteins were run
through a mini C18 column (Pharmacia) and eluted with 80%
acetonitrile containing 1% formic acid before performing ESI-MS
analysis (MicroMass ZMD).
2.6. ThT ﬂuorescence assay
The kinetics of ﬁbril formation was monitored with ThT ﬂuores-
cence in sample mixtures containing 72 μM α-synuclein, 100 mM
NaCl/100 mM phosphate buffer, and 20 μM ThT at pH 7.4. Protein
solutions were airfuged at 20,000 rpm for 40min to remove oligomers
and aggregates from solution. ThT was dissolved in water, ﬁltered and
the concentration determined at 25 °C using an extinction coefﬁcient
of ɛ412 nm=36,000 M−1cm−1. Plate reader measurements were carried
out in 96-well plates at 37 °C, with 600 rpm shaking with 2 mm
shaking diameter, and containing 1/8 in Teﬂon beads. The solutionwas
excited at 444 nm, and emission was measured at 485 nm. The
intensity at 485 nm was recorded in replicates of ﬁve to verify
reproducibility, errors were b10%.
2.7. FTIR spectra
Attenuated total reﬂectance (ATR) Fourier Transform Infrared
spectra were collected on a Nexus 670 FTIR instrument (Thermo-
Nicolet, Madison, WT). Protein samples (0.5 mg/mL, 50 μL volume)
were spread out and dried as a thin ﬁlm on a germanium IRE, with
a constant ﬂow of nitrogen gas. 250 interferograms were collected
for each sample. Data analysis was performed with the GRAMS32
software from Galactic Industries. Secondary structure components
and percentages were estimated by curve ﬁtting following Fourier
self-deconvolution and second derivative [15].
2.8. Circular dichroism (CD) measurements
CD spectra were obtained with an AVIV 62DS spectrophotometer
(Lakewood, NJ) using protein concentrations of 2.0 mg/mL at pH 7.4
(100 mM phosphate/100 mM NaCl buffer). Spectra were recorded in a
0.2 mm pathlength cylindrical for the far-UV (190–250 nm) and
10 mm quartz cell (Starna, Atascadero, CA) for the near-UV (250–
310 nm) CD measurements with a step size of 0.5 nm, bandwidth of
1.5 nm, and an averaging time of 3 s. For all spectra, an average of 3
scans was obtained. CD spectra of appropriate buffers were recorded
and subtracted from the protein spectra. The mean residue ellipticity,
[Θ]λ, was calculated by using the relation
Θ½ λ =
MoΘλ
100  c  l ð1Þ
in which Mo is the mean residue molar mass (103.3 g·mol−1 for α-
synuclein), Θλ is the measured ellipticity in degrees, c is the con-
centration in g/mL, and l is the path length in decimeters. [Θ]λ was
expressed in deg cm2 dmol−1. Secondary structure content was
calculated from the far-UV-CD spectra using the CONTIN software
package [16].
2.9. Native gel electrophoresis
Native PAGE was performed on a PHAST system (Amersham
Pharmacia Biotech, Uppsala, Sweden) according to instructions
provided by the manufacturer. Protein solutions were prepared as
described above except the samples were not ultra-centrifuged.
After 3 h, the protein samples with a concentration of 4.0 mg/mL
were applied to the 20% gel. After electrophoresis, gels were
Coomassie blue-stained and protein bands were quantiﬁed using
Fig. 2. Native PAGE electrophoretogram of wild-type α-synuclein and its mutants: Y39A,
Y125A, Y133A, Y136A and Y(125, 133, 136)A. Protein concentrations were 4 mg/mL.
Protein solutions were prepared 3 hours before the samples were applied to the 20% gel.
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3. Results and discussion
Protein conformation-dependent toxicity is an emerging theme in
neurodegenerative disorders, including the synucleinopathies [17].
The native proteins are generally not thought to be pathogenic,
however they are the reservoir providing the alternative conforma-
tions and quaternary structures that lead to toxic species, believed to
be critical for neurodegeneration and neuroimpairment. The shift in
equilibrium from benign to malignant conformations is currently
thought to be the underlying cause or contributing factor to the
pathogenesis. In this context, the more stable the native state, the
lower the risk of the conformational change to the pathogenic
conformer associated with the diseased state. The situation is
somewhat more complex when dealing with an intrinsically dis-
ordered protein, such as α-synuclein. Several observations suggest
that interactions between the C-terminal “tail” and the central region
of α-synuclein may minimize aggregation/ﬁbrillation, perhaps by
preventing intermolecular interactions between the hydrophobic
central NAC domain. The majority of hydrophobic interactions in the
C-terminal 20 residues of α-synuclein emanate from the three Tyr
residues. Thus, mutation of these residues to Ala provides insight into
their contributions to the structure and aggregation of α-synuclein.
3.1. Impact of Tyr → Ala mutations on the ﬁbrillation of human
α-synuclein
Protein aggregation and ﬁbrillation kinetics typically appear
sigmoidal, usually attributed to a nucleated polymerization process
in which the initial lag phase corresponds to the requirement for
formation of a critical nuclei, the subsequent exponential growth
phase corresponds to ﬁbril elongation, and the ﬁnal plateau is ascribed
to exhaustion of soluble monomers and intermediates. The kinetics of
ﬁbrillation for wild-type and Tyr → Ala mutant recombinant human
α-synucleins were monitored using Thioﬂavin T (ThT) ﬂuorescence.
The histological dye, ThT, is widely used for the detection of amyloid
ﬁbrils which give rise to a new excitation maximum at 444 nm and
enhanced emission at 485 nm. Unbound ThT in solution is essentially
non-ﬂuorescent at these wavelengths. ThT is believed to bind
speciﬁcally to the crossed β-sheet structure associated with amy-
loid-type ﬁbrils and the binding is independent of the primaryFig. 1. Kinetics of ﬁbril formation by wild-type α-synuclein and its mutants: Y39A,
Y125A, Y133A, Y136A and Y(125,133,136)A monitored by ThT ﬂuorescence at 37 °C. Key:
WT (●), Y39A (○), Y125A (▲), Y133A (■), Y136A (□) and Y(125,133,136)A (△).
Conditions: 100 mM NaCl, 100 mM phosphate buffer pH 7.4, 20 μM ThT, protein
concentration 1.0 mg/mL.structure of the protein. Only the ﬁbrillar forms give rise to signiﬁcant
ﬂuorescence upon ThT binding. The binding of ThT to α-synuclein
ﬁbrils is therefore an effective and speciﬁc method for monitoring the
ﬁbrillation process. The data in Fig. 1 indicate that changing the
tyrosine residues in α-synuclein to alanine signiﬁcantly impedes ﬁbril
formation. For example, complete inhibition of ﬁbril formation was
observed after replacing Tyr with Ala at all three positions 125, 133
and 136 simultaneously, or at position 39 alone. These observations
are consistent with a critical interaction between the cluster of three
Tyr residues at the C-terminus and Tyr39. We propose that Tyr39 and
the C-terminal Tyr residues form an aromatic cluster, which could also
involve additional hydrophobic residues, such as the two C-terminal
Met residues. Interestingly, comparison of the effects of the individual
Tyr to Ala substitutions shows that Y133 has a much more signiﬁcant
contribution than either Y125 or Y136. This could mean a more
speciﬁc hydrophobic interaction between Y133 and Y39. These data
clearly indicate the importance of Tyr's located at these positions for
intra- or intermolecular interactions between the N- and C-termini of
α-synuclein. Although the interactions between the N- and C-termini
are expected to be mostly electrostatic, the C-terminus may form
hydrophobic interactions with the central NAC domain of α-synuclein
[9,13], as well as with Y39. Several observations suggest that the
critical ﬁbrillogenic region of α-synuclein involves the relatively
hydrophobic NAC region, residues 61–92. Although it is reasonable to
propose that the intramolecular interactions between the C-terminus
and Y39 and other parts of the central or N-terminal region, will lead
to potential steric occlusion of parts of the NAC region from
intermolecular interactions, thus preventing aggregation/ﬁbrillation,
our data clearly argue against this. In fact, decreasing these
interactions by replacing the Tyr's with Ala leads to decreased
ﬁbrillation; this could result from (i) stabilization of the monomeric
state, (ii) stabilization of the oligomeric states or (iii) from decreased
intermolecular interactions leading to ﬁbrillation. Since the Tyr to Ala
mutations lead to increased exposure of the hydrophobic central
domain of the molecule, we favor the latter explanation. However, the
observation of some oligomeric states for Tyr → Ala mutants on
native-PAGE electrophoretogram (Fig. 2) suggest the presence of some
intermolecular interactions which could lead to the formation of
soluble nonﬁbrillating oligomers.
3.2. Impact of Tyr → Ala mutations on the secondary structure of
α-synuclein
The secondary structure of α-synuclein and its Tyr to Ala mutants
was investigated with FTIR, which is more sensitive to β-structure
than CD. FTIR spectra for wild-type and the mutant α-synucleins are
shown in Fig. 3A. The spectra of all the Tyr → Ala mutants had less
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less β-structure as compared to the wild-type protein.
Deconvoluted amide I spectra for each protein were generated by
second-derivative analysis (Fig. 3B). The peaks in the vicinity of 1638
and 1625 cm−1 can be assigned to β-sheet components, and the major
band at 1657 cm−1 is assigned to a disordered structure [18–20]. In the
spectrum of the wild-type α-synuclein, the main band for β-structure
is at 1625 cm−1, whereas for all the mutants the major β-structure
band is in the vicinity of 1638 cm−1 (Fig. 3B). In the absence of local
environmental effects this suggests that there is a major change from
antiparallel β-sheet in the wild-type to parallel β-sheet in the
mutants. Insight into the Fig. 3B reveals that the most intense band
at position 1638 cm−1 is for Y133A, while the least intense peak is for
wild-type α-synuclein.
The most intense band in all the second-derivative spectra is at
∼1656 cm−1 and is assigned to a disordered (and possibly helical)
structure and is strongest for the Y39A mutant. The bands located at
1688, 1680, 1672, and 1666 cm−1 are assigned to various types of loop
and turn structures [18]. These peaks are much more pronounced in
the mutated forms of α-synuclein, suggesting a more complex struc-
ture than for the wild-type. The deconvoluted FTIR spectra show that
the secondary structure for the mutant α-synucleins is signiﬁcantly
different from that of wild-type. It is presumably this change in
conformation that is responsible for the different propensity of the
mutants compared to wild-type for ﬁbrillation.
The secondary structure of wild-type and Tyr → Ala mutant α-
synucleins was also examined by CD (100 mM sodium phosphate pH
7.4/100 mM NaCl buffer) (Fig. 4A). Circular dichroism is much more
sensitive to a helical structure than FTIR, in the latter bands for dis-Fig. 3. FTIR spectra (A) and their 2nd derivative (B) of wild-type α-synuclein and its
mutants: Y39A, Y125A, Y133A, Y136A and Y(125, 133, 136)A. Conditions: 100 mM NaCl,
100 mM phosphate buffer pH 7.4, protein concentration 0.5 mg/mL.ordered and helical structures are very close and frequently difﬁcult to
separate. The spectrum of α-synuclein at pH 7.4 is characterized by a
negative CD band near 200 nm (Fig. 4A). Whereas the spectra of Y39A
and Y125A had a minimum at 200–202 nm, two other mutants
showed an increased minima: Y136A at 204 nm and Y(125,133,136)A
at 205 nm, indicative of some increased structure/compactness. In
marked contrast, the Y133A mutant has a far-UV-CD spectrum, which
is characteristic of α-helix. Based on CONTIN analysis, α-synuclein in
aqueous solution at pH 7.4 contains 19±1% α-helix, Y39A 12±2% α-
helix, Y125A 25±2 α-helix, Y133A 88±6% α-helix, Y136A 20±2% α-
helix and Y(125,133,136)A 26±2% α-helix. Replacement of Tyr with
Ala at position 39 leads to a decrease in the quantity of α-helical
structures but an increase in the amount of turns, while the
replacement of Tyr with Ala at position 133 drastically increases the
amount of helical structures."; This major conformational change also
correlates with the largest effect on ﬁbrillation. It is interesting that
the triple Tyr→ Ala mutant did not have signiﬁcantly more helix than
the wild-type α-synuclein.
Analysis of the CD spectra shows that the other mutants have
similar amounts of β-sheet structure as wild-type α-synuclein.
Application of different secondary structure prediction algorithms
on the primary structure ofα-synuclein did not predict much increase
in the amount of α-helical structures for the mutants. However, the
program AGADIR, designed for the prediction of a secondary structure
for peptides [21], predicted an increase in the amount of α-helix from
46% to approx. 75%, regardless of the position of the Tyr to Ala
mutation. Based on the FTIR and CD data we conclude that
replacement of the Tyr to Ala decreases the amount of β-structure
and induces the formation of more α-helical structure. The near-UV-
CD spectra did not show any induced tertiary interactions (Fig. 4B),
although some higher oligomeric states of Tyr → Ala mutants were
detected on native-PAGE electrophoretogram (Fig. 2).
Amino acid bulkiness, the ratio of side chain volume to its length,
predicts clearly observable features reporting on the local conforma-
tional behavior of intrinsically disordered proteins. Alanine has a
higher α-helical preference than the bulkier side chain of tyrosine,
which prefers to form a beta sheet structure. Favorable long-range
intramolecular interactions of α-synuclein have been observed
between a hydrophobic cluster that comprises the C-terminal part
of the highly hydrophobic NAC region (residues 85–95) and the C-
terminus (residues 110–130) probably mediated by Met116, Val118,
Tyr125 and Met127 [9]. Within the C-terminal domain, residues 120–
130 contact residues 105–115, and the region above residue 120 also
interacts with the N-terminus above residue 20. These interactions
presumably inhibit spontaneous α-synuclein oligomerization and are
compatible with the inﬂuence of ﬁbrillation exerted by methionine
oxidation, tyrosine nitration and phosphorylation of Ser 129 [22–27].
The signiﬁcant stabilization of the natively unfolded conformation has
been shown to represent a contributing factor to the inhibition of
methionine-oxidized α-synuclein ﬁbrillation [23]. Nitration of tyr-
osines leads to formation of partially folded conformations, which are
stabilized by formation of speciﬁc oligomers, most likely octamers.
These octamers are stable and possess decreased conformational
ﬂexibility, as seen by the increase in resistance towards limited pro-
teolysis [24,25].
The ﬁndings that Tyr to Ala mutants do not form any partially
folded conformations but they exhibit differing folding ﬂexibility, a
dissimilar secondary structure and differing aggregation propensity
are in agreementwith the our current understanding thatα-synuclein
can adopt diverse conformations. From comparison of the effects of
speciﬁc Tyr → Ala mutations in terms of the conformational effects
versus the kinetics of ﬁbrillation it is clear that there are several diffe-
rent factors involved. The individual mutation having the largest effect
on the structure, Y133A, also has the largest effect in inhibiting ﬁbril-
lation. This observation suggests that inducing the helical conforma-
tion observed in this mutation prevents ﬁbrillation, thus, low
Fig. 4. Far-UV (A) and near-UV (B) CD spectra of wild-type α-synuclein and its mutants:
Y39A, Y125A, Y133A, Y136A and Y(125, 133, 136)A. Conditions: 100 mM NaCl, 100 mM
phosphate buffer pH 7.4, protein concentration 2.0 mg/mL.
585N.P. Ulrih et al. / Biochimica et Biophysica Acta 1782 (2008) 581–585molecular weight compounds that would induce a similar conforma-
tion might be effective at preventing α-synuclein ﬁbrillation in vivo.
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